Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.

<h4>Background</h4>Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically sil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna Enjuanes, Verònica Fernàndez, Luis Hernández, Alba Navarro, Sílvia Beà, Magda Pinyol, Armando López-Guillermo, Andreas Rosenwald, German Ott, Elías Campo, Pedro Jares
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/69e86e41d29b42ba9e4a8e9ac3fe8e43
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:69e86e41d29b42ba9e4a8e9ac3fe8e43
record_format dspace
spelling oai:doaj.org-article:69e86e41d29b42ba9e4a8e9ac3fe8e432021-11-18T06:53:56ZIdentification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.1932-620310.1371/journal.pone.0019736https://doaj.org/article/69e86e41d29b42ba9e4a8e9ac3fe8e432011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21603610/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically silenced genes in these tumours that might have clinical relevance.<h4>Methodology/principal findings</h4>To identify potential methylated genes in MCL we initially investigated seven MCL cell lines treated with epigenetic drugs and gene expression microarray profiling. The methylation status of selected candidate genes was validated by a quantitative assay and subsequently analyzed in a series of primary MCL (n = 38). After pharmacological reversion we identified 252 potentially methylated genes. The methylation analysis of a subset of these genes (n = 25) in the MCL cell lines and normal B lymphocytes confirmed that 80% of them were methylated in the cell lines but not in normal lymphocytes. The subsequent analysis in primary MCL identified five genes (SOX9, HOXA9, AHR, NR2F2, and ROBO1) frequently methylated in these tumours. The gene methylation events tended to occur in the same primary neoplasms and correlated with higher proliferation, increased number of chromosomal abnormalities, and shorter survival of the patients.<h4>Conclusions</h4>We have identified a set of genes whose methylation degree and gene expression levels correlate with aggressive clinicopathological features of MCL. Our findings also suggest that a subset of MCL might show a CpG island methylator phenotype (CIMP) that may influence the behaviour of the tumours.Anna EnjuanesVerònica FernàndezLuis HernándezAlba NavarroSílvia BeàMagda PinyolArmando López-GuillermoAndreas RosenwaldGerman OttElías CampoPedro JaresPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 5, p e19736 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anna Enjuanes
Verònica Fernàndez
Luis Hernández
Alba Navarro
Sílvia Beà
Magda Pinyol
Armando López-Guillermo
Andreas Rosenwald
German Ott
Elías Campo
Pedro Jares
Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
description <h4>Background</h4>Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically silenced genes in these tumours that might have clinical relevance.<h4>Methodology/principal findings</h4>To identify potential methylated genes in MCL we initially investigated seven MCL cell lines treated with epigenetic drugs and gene expression microarray profiling. The methylation status of selected candidate genes was validated by a quantitative assay and subsequently analyzed in a series of primary MCL (n = 38). After pharmacological reversion we identified 252 potentially methylated genes. The methylation analysis of a subset of these genes (n = 25) in the MCL cell lines and normal B lymphocytes confirmed that 80% of them were methylated in the cell lines but not in normal lymphocytes. The subsequent analysis in primary MCL identified five genes (SOX9, HOXA9, AHR, NR2F2, and ROBO1) frequently methylated in these tumours. The gene methylation events tended to occur in the same primary neoplasms and correlated with higher proliferation, increased number of chromosomal abnormalities, and shorter survival of the patients.<h4>Conclusions</h4>We have identified a set of genes whose methylation degree and gene expression levels correlate with aggressive clinicopathological features of MCL. Our findings also suggest that a subset of MCL might show a CpG island methylator phenotype (CIMP) that may influence the behaviour of the tumours.
format article
author Anna Enjuanes
Verònica Fernàndez
Luis Hernández
Alba Navarro
Sílvia Beà
Magda Pinyol
Armando López-Guillermo
Andreas Rosenwald
German Ott
Elías Campo
Pedro Jares
author_facet Anna Enjuanes
Verònica Fernàndez
Luis Hernández
Alba Navarro
Sílvia Beà
Magda Pinyol
Armando López-Guillermo
Andreas Rosenwald
German Ott
Elías Campo
Pedro Jares
author_sort Anna Enjuanes
title Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
title_short Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
title_full Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
title_fullStr Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
title_full_unstemmed Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
title_sort identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/69e86e41d29b42ba9e4a8e9ac3fe8e43
work_keys_str_mv AT annaenjuanes identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT veronicafernandez identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT luishernandez identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT albanavarro identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT silviabea identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT magdapinyol identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT armandolopezguillermo identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT andreasrosenwald identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT germanott identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT eliascampo identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
AT pedrojares identificationofmethylatedgenesassociatedwithaggressiveclinicopathologicalfeaturesinmantlecelllymphoma
_version_ 1718424234370269184